Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naval Daver

Showing results (71-80 of 436) with videos related to

Pageof 44
Sort By:
BBA Clinical|January 11, 2017
Hemophagocytic lymphohistiocytosis in adults: An under recognized entityAbdul Rashid Shah, Tariq Muzzafar, Rita Assi, et al.
European Journal of Haematology|December 12, 2017
Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosisLucia Masarova, Ahmad Alhuraiji, Prithviraj Bose, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2021
Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib TherapyLucia Masarova, Prithviraj Bose, Naveen Pemmaraju, et al.
Leukemia|July 12, 2020
MDM2 inhibition: an important step forward in cancer therapyMarina Konopleva, Giovanni Martinelli, Naval Daver, et al.
Annals of Hematology|August 5, 2021
Phase II study of single-agent nivolumab in patients with myelofibrosisIman Abou Dalle, Hagop Kantarjian, Naval Daver, et al.
American Journal of Hematology|January 23, 2016
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutationPreetesh Jain, Guilin Tang, Yang O Huh, et al.
Frontiers in Oncology|January 27, 2022
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid LeukemiaOren Pasvolsky, May Daher, Gheath Alatrash, et al.
Frontiers in Immunology|March 7, 2022
Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary MucormycosisSebastian Wurster, Nathaniel D Albert, Uddalak Bharadwaj, et al.
Leukemia & Lymphoma|August 6, 2016
Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical studyKiran Naqvi, Naval Daver, Naveen Pemmaraju, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 4, 2022
Microsatellite Instability Assessment by Immunohistochemistry in Acute Myeloid Leukemia: A Reappraisal and Review of the LiteratureSiba El Hussein, Naval Daver, Jing-Lan Liu, et al.
Pageof 44

Showing results (71-80 of 436) with videos related to

Sort By:
Pageof 44
BBA Clinical|January 11, 2017
Hemophagocytic lymphohistiocytosis in adults: An under recognized entityAbdul Rashid Shah, Tariq Muzzafar, Rita Assi, et al.
European Journal of Haematology|December 12, 2017
Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosisLucia Masarova, Ahmad Alhuraiji, Prithviraj Bose, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2021
Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib TherapyLucia Masarova, Prithviraj Bose, Naveen Pemmaraju, et al.
Leukemia|July 12, 2020
MDM2 inhibition: an important step forward in cancer therapyMarina Konopleva, Giovanni Martinelli, Naval Daver, et al.
Annals of Hematology|August 5, 2021
Phase II study of single-agent nivolumab in patients with myelofibrosisIman Abou Dalle, Hagop Kantarjian, Naval Daver, et al.
American Journal of Hematology|January 23, 2016
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutationPreetesh Jain, Guilin Tang, Yang O Huh, et al.
Frontiers in Oncology|January 27, 2022
CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid LeukemiaOren Pasvolsky, May Daher, Gheath Alatrash, et al.
Frontiers in Immunology|March 7, 2022
Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary MucormycosisSebastian Wurster, Nathaniel D Albert, Uddalak Bharadwaj, et al.
Leukemia & Lymphoma|August 6, 2016
Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical studyKiran Naqvi, Naval Daver, Naveen Pemmaraju, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 4, 2022
Microsatellite Instability Assessment by Immunohistochemistry in Acute Myeloid Leukemia: A Reappraisal and Review of the LiteratureSiba El Hussein, Naval Daver, Jing-Lan Liu, et al.
Pageof 44